Pay in 4 interest-free payments of $272.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Major group rhinovirus receptor
IFN-λ2 is considered a promising therapeutic agent for the treatment of viral infections due to its potent antiviral properties and reduced potential for side effects compared to type I interferons
Acta Crystallographica Section D Biological Crystallography
heterodimerizes with its partner ARNT (HIF-1β)
UniOne® TR-FRET Human BCL-XL/CRBN PROTAC Binding Kit Size:2500T Major group rhinovirus receptorProduct Specification Host Human Stability & Storage 80 Background The assay kit employs homogeneous time resolved fluorescence (TR FRET) technology to measure the interaction between the DDB1 CRBN complex and BCL XL mediated by the molecular glue XZ739 and test compounds. This method enables a simple, rapid, and high throughput screening of small molecules capable of mediating the interaction between the DDB1 CRBN complex and BCL XL. As shown in the